NR2F6 antibody

Cat.#: 107337

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    NR2F6 antibody
  • Documents
  • Description
    NR2F6 Mouse Monoclonal antibody. Positive IHC detected in human kidney tissue. Positive WB detected in MCF-7 cells, MCF7 cells. Observed molecular weight by Western-blot: 42 kDa
  • Tested applications
    ELISA, WB, IHC
  • Species reactivity
    Human; other species not tested.
  • Alternative names
    EAR 2 antibody; EAR2 antibody; ERBAL2 antibody; NR2F6 antibody; V erbA related protein 2 antibody
  • Isotype
    Mouse IgG1
  • Preparation
    This antibody was obtained by immunization of NR2F6 recombinant protein (Accession Number: NM_005234). Purification method: .
  • Clonality
    Monoclonal
  • Formulation
    PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:500-1:5000

    IHC: 1:20-1:200

  • Validations

    Immunohistochemical of paraffin-embedded human kidney using Catalog No:107337(NR2F6 antibody) at dilution of 1:50 (under 40x lens)

    Immunohistochemical of paraffin-embedded human kidney using Catalog No:107337(NR2F6 antibody) at dilution of 1:50 (under 40x lens)

    MCF-7 cells were subjected to SDS PAGE followed by western blot with Catalog No:107337(NR2F6 Antibody) at dilution of 1:1000

    MCF-7 cells were subjected to SDS PAGE followed by western blot with Catalog No:107337(NR2F6 Antibody) at dilution of 1:1000

  • Background
    NR2F6 belongs to NR2F subfamily members, which have their roles in the regulation of neurogenesis, organogenesis, and cellular differentiation during embryonic development [PMID:15875024]. NR2F6 acts as transcription factor by binding to a TGACCT direct-repeat motif and has been established in controlling facets of central nervous system (CNS) [12690040]. It is a nuclear attenuator that directly interferes with DNA binding of NF-AT and, subsequently, transcriptional activity of the NF-AT-dependent IL-17 expression. Otherwise, NR2F6 negatively interfered with transcriptional cytokine responses and acted as a barrier against autoimmunity [PMID:18701084].

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"